Dr Theresa Buszta, RPH is a
Pharmacist based in Montgomeryville, Pennsylvania. Dr Theresa Buszta is licensed to practice in Pennsylvania (license number RPH450162) and her current practice location is
100 Corporate Dr Ste 2, Montgomeryville, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at
(215) 639-6162.
NPI number for Dr Theresa Buszta is 1578283016 and her current mailing address is 100 Corporate Dr Ste 2, Montgomeryville, Pennsylvania. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1578283016.
Healthcare Provider's Profile
| Full Name | Dr Theresa Buszta |
|---|
| Gender | Female |
|---|
| Speciality | Pharmacist |
|---|
| Location | 100 Corporate Dr Ste 2, Montgomeryville, Pennsylvania |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1578283016
- Provider Enumeration Date: 09/02/2022
- Last Update Date: 04/29/2026
Medical Identifiers
Medical identifiers for Dr Theresa Buszta such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1578283016 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 183500000X | Pharmacist | RPH450162 (Pennsylvania) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Theresa Buszta is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Dr Theresa Buszta, RPH 100 Corporate Dr Ste 2, Montgomeryville, PA 18936-9644 Ph: (215) 639-6162 | Dr Theresa Buszta, RPH 100 Corporate Dr Ste 2, Montgomeryville, PA 18936-9644 Ph: (215) 639-6162 |
Reviews and Comments